Why do antimicrobial agents become ineffectual?

被引:4
作者
Inoue, M
Kuga, A
Shimauchi, C
Yano, H
Okamoto, R
机构
[1] Kitasato Univ, Sch Med, Dept Microbiol, Sagamihara, Kanagawa 2288555, Japan
[2] Kitasato Univ, Grad Sch Med Sci, Dept Environm Infect Dis, Sagamihara, Kanagawa 2288555, Japan
关键词
emergence of resistance; nosocomial spread; C-max/MIC80; MRSA; coagulase type; PFGE patterns;
D O I
10.3349/ymj.1998.39.6.502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antibiotic resistance has evolved over the past 50 years from a merely microbiological curosity to a serious medical problem in hospitals all over the world. Resistance has been reported in almost all species of gram-positive and -negative bacteria to various classes of antibiotics including recently developed ones. Bacteria acquire resistance by reducing permeability and intracellular accumulation, by alteration of targets of antibiotic action, and by enzymatic modification of antibiotics. Inappropriate use of an antibiotic selects resistant strains much more frequently. Once resistant bacteria has emerged, the resistance can be transferred to other bacteria try various mechanisms, resulting in multiresistant strains. MRSA is one of the typical multiresistant nosocomial pathogens. A study of the PFGE pattern of endonuclease-digested chromosomal DNA showed that MRSA of a few clones were disseminated among newborns in the NICU of a Japanese hospital. In this regard, it is important to choose appropriate antibiotics and then after some time to change to other classes to reduce the selection of resistant strains. Since the development of epoch-making: neu antibiotics is nor expected in the near future, it has become very important to use existing antibiotics prudently based on mechanisms of antibiotic action and bacterial resistance. Central of nosocomial infection is also very important to reduce further spread of resistant bacteria.
引用
收藏
页码:502 / 513
页数:12
相关论文
共 42 条
[2]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[3]   Antibiotic resistance - what can we do? [J].
Bax, RP ;
Anderson, R ;
Crew, J ;
Fletcher, P ;
Johnson, T ;
Kaplan, E ;
Knaus, B ;
Kristinsson, K ;
Malek, M ;
Strandberg, L .
NATURE MEDICINE, 1998, 4 (05) :545-546
[4]   Emergence of vancomycin-resistant enterococci in Australia: Phenotypic and genotypic characteristics of isolates [J].
Bell, JM ;
Paton, JC ;
Turnidge, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (08) :2187-2190
[5]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233
[6]   CHARACTERIZATION OF BETA-LACTAMASE INDUCTION IN ENTEROBACTER-CLOACAE [J].
GOOTZ, TD ;
SANDERS, CC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (01) :91-97
[7]   ROLE OF PROTEIN-F IN MAINTAINING STRUCTURAL INTEGRITY OF THE PSEUDOMONAS-AERUGINOSA OUTER-MEMBRANE [J].
GOTOH, N ;
WAKEBE, H ;
YOSHIHARA, E ;
NAKAE, T ;
NISHINO, T .
JOURNAL OF BACTERIOLOGY, 1989, 171 (02) :983-990
[8]   OUTER-MEMBRANE GRAM-NEGATIVE BACTERIA .20. IDENTIFICATION OF THE PROTEIN PRODUCING TRANSMEMBRANE DIFFUSION PORES IN THE OUTER-MEMBRANE OF PSEUDOMONAS-AERUGINOSA PA01 [J].
HANCOCK, REW ;
DECAD, GM ;
NIKAIDO, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 554 (02) :323-331
[10]   INHIBITION OF BETA-LACTAMASES BY TAZOBACTAM AND INVITRO ANTIBACTERIAL ACTIVITY OF TAZOBACTAM COMBINED WITH PIPERACILLIN [J].
HIGASHITANI, F ;
HYODO, A ;
ISHIDA, N ;
INOUE, M ;
MITSUHASHI, S .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (04) :567-574